Doctor
Tracy DuddingProfile page
Clinical Conjoint Professor
School of Medicine and Public Health
- Clinical Conjoint ProfessorSchool of Medicine and Public Health
- 0249853100 (Work)
BIOGRAPHY
Professor Tracy Dudding-Byth AM works as a Consultant Clinical Geneticist within the NSW Genetics of Learning Disability (GOLD) Service, Hunter Genetics, NSW Australia. She is a clinician-researcher in the field of neurofibromatosis type 1, rare genetic diseases, obtaining her PhD in 2012. She was a founding co-director of Rare Voices Australia, a national advocacy organisation uniting the estimated 1.5 million Australians living with a rare disease. In 2024, Professor Dudding-Byth was awarded a Member of the Order of Australia for her outstanding contribution to research and patient advocacy.
Research interests:
My research interests include identifying the genetic modifiers affecting the severity of neurofibromatosis type 1 (NF1) to develop a targeted treatment for individuals with this condition; and the use of 2D facial recognition technology to improve the diagnostic rate for children with syndromic intellectual disability. The FaceMatch computer vision platform (facematch.org.au) is the first and only combined clinician and computer vision initiative to integrate facial matching over the age spectrum with human phenome ontology terms and genomic variant data. Dr Dudding-Byth recieved the 2021 Research Australia Health and Medical Research Data Innovation award for developing the FaceMatch project.
Neurofibromatosis Research:
Neurofibromatosis type 1 Cutaneous Neurofibroma Consortium is a research project funded by a $1.6M grant from the Medical Research Future Fund which I am leading. It aims to increase the understanding of how genetics influences the number of skin neurofibromas a person with NF1 may develop and how to treat neurofibromas in the future.
The study is open to adults with clinical or genetic diagnosis of NF1. Participants can register at NF1 project
Neurofibromatosis type 1 (NF1) is one the most common neurogenetic conditions with a prevalence of 1 in 2500. Children and adults with this condition have an increased lifetime risk of benign and malignant tumours affecting the skin and nervous system. There are no current treatment for cutaneous neurofibromas which have an incredibly high physical and psychological burden for affected individuals. I believe that studying this condition will provide insights into the pathogenesis of more common cancers.
Publications:
Research output includes 33 publications (11 first or senior author) and 1 PhD Thesis. This includes 1 Nature and 2 Nature Genetics publications as part of the KConFab consortium. Citation index:14
Contribution to field of research:
As a clinical researcher, Dr Dudding-Byth has phenotypically and molecularly characterised a novel form of intellectual disability (Omim 117360) (Dudding et al., Neurology 2004; Huang et al Orphanet J Rare dis. 2012) and a novel form of oesophageal achalasia (Dudding et al., 2010 Clin Genet). She has extended the phenotypic characterisation of four genetic causes of intellectual disability. Her work exploring the relationship between inherited thrombophilia and adverse pregnancy outcome (Dudding et al., Thrombosis and Haemostasis 2004; Dudding et al J Thrombosis and Haemostasis) is referenced within UptoDate: Inherited thrombophilia and pregnancy; Gene reviews- inherited thrombophilia; and in the British Journal of Haematology: clinical guidelines for the testing for inherited thrombophilia.
International collaboration:
The GOLD service has well established collaborations with the Max Planck institute, Germany and the Wellcome Trust Sanger Institute, England. Care4Rare collaboration led to the identification of the gene for SCA29. Dr Dudding-Byth is leading an innovative project with Professor Brian Lovell from The University of Queensland evaluating the use of 2D facial recognition technology for matching the gestalt of individuals with known and unknown syndromic forms of intellectual disability [Oral presentation HGSA conference August 2015].
Research Support:
Chief Investigator on University of Newcastle Grow-Up-Well Priority Research Centre Grant 2015. HNEhealth 2015 Innovation Scholarship: " The FaceMatch Project: Matching the faces of individuals with undiagnosed syndromic intellectual disability".
Community engagement:
Co-founding director of Rare Voices Australia. Dr Dudding-Byth sits on the Medical Advisory Committee of the Steve Waugh Foundation, a charity for children with rare diseases.
2013: Invited speaker: RCPA Pathology:Australasian Division 37th Annual Scientific Meeting. Orphan Diseases: Challenges, Costs and Opportunities
2015: RACGP invited manuscript submission: A Powerful team: the family physician advocating for patients with a rare disease.
Supervision and mentoring:
Dr Dudding-Byth is supervising 3 higher degree students in the field of rare disease research. She supervises medical students during their year 5 Special Study Option to write and publish a first author medical case report. Awarded HCRF 2015 Research Mentor of the year.
Research Expertise: Neurofibromatosis type 1; intellectual disability; rare disease patient advocacy; clinical genetics; rare genetic diseases; medical genetics; 2D facial recognition technology in dysmorphology
UNIVERSITY OF NEWCASTLE APPOINTMENTS
- Clinical Conjoint ProfessorUniversity of Newcastle, School of Medicine and Public Health, Australia9 Dec 2010 - present
NON-ACADEMIC POSITIONS
- HNEHealth 2016 Clinical Research FellowHunter New England Area Health Service, Australia1 Feb 2017 - 1 Feb 2020
- Senior Staff Specialist NSW GOLD ServiceHunter Genetics, Hunter Area Health Service, Australia1 Jan 2013 - present
- Senior Staff Specialist Clinical GeneticsHunter Genetics, Hunter Area Health Service, Australia1 Jan 2013 - present
DEGREES
- Doctor of PhilosophyUniversity of Newcastle, Australia8 Aug 2012
- Bachelor of MedicineUniversity of Newcastle, Australia31 Dec 1990
PROFILE TYPE
- Conjoint
DISCIPLINE
- Medical Genetics